###begin article-title 0
Mowat-Wilson syndrome
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 1034 1038 1034 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2</italic>
###xml 1058 1065 1058 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZFHX1B </italic>
###xml 1709 1714 1709 1714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 809 817 <span type="species:ncbi:9606">patients</span>
###xml 908 916 <span type="species:ncbi:9606">patients</span>
###xml 1133 1141 <span type="species:ncbi:9606">patients</span>
###xml 1527 1535 <span type="species:ncbi:9606">patients</span>
###xml 2135 2143 <span type="species:ncbi:9606">patients</span>
Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a distinct facial phenotype (high forehead, frontal bossing, large eyebrows, medially flaring and sparse in the middle part, hypertelorism, deep set but large eyes, large and uplifted ear lobes, with a central depression, saddle nose with prominent rounded nasal tip, prominent columella, open mouth, with M-shaped upper lip, frequent smiling, and a prominent but narrow and triangular pointed chin), moderate-to-severe intellectual deficiency, epilepsy and variable congenital malformations including Hirschsprung disease (HSCR), genitourinary anomalies (in particular hypospadias in males), congenital heart defects, agenesis of the corpus callosum and eye anomalies. The prevalence of MWS is currently unknown, but 171 patients have been reported so far. It seems probable that MWS is under-diagnosed, particularly in patients without HSCR. MWS is caused by heterozygous mutations or deletions in the Zinc finger E-box-binding homeobox 2 gene, ZEB2, previously called ZFHX1B (SIP1). To date, over 100 deletions/mutations have been reported in patients with a typical phenotype; they are frequently whole gene deletions or truncating mutations, suggesting that haploinsufficiency is the main pathological mechanism. Studies of genotype-phenotype analysis show that facial gestalt and delayed psychomotor development are constant clinical features, while the frequent and severe congenital malformations are variable. In a small number of patients, unusual mutations can lead to an atypical phenotype. The facial phenotype is particularly important for the initial clinical diagnosis and provides the hallmark warranting ZEB2 mutational analysis, even in the absence of HSCR. The majority of MWS cases reported so far were sporadic, therefore the recurrence risk is low. Nevertheless, rare cases of sibling recurrence have been observed. Congenital malformations and seizures require precocious clinical investigation with intervention of several specialists (including neonatologists and pediatricians). Psychomotor development is delayed in all patients, therefore rehabilitation (physical therapy, psychomotor and speech therapy) should be started as soon as possible.
###end p 2
###begin title 3
Disease name
###end title 3
###begin p 4
Mowat-Wilson syndrome
###end p 4
###begin title 5
Definition
###end title 5
###begin p 6
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 660 665 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 830 831 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 832 833 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Mowat-Wilson syndrome (MWS; MIM# 235730) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene, and characterized by typical face, moderate-to-severe mental retardation, epilepsy and variable congenital malformations, including Hirschsprung disease (HSCR), genital anomalies (particularly hypospadias in males), congenital heart disease (CHD), agenesis of the corpus callosum (ACC) and eye defects. The clinical aspects of the syndrome were first described by Mowat et al in 1998, who also identified a locus at chromosome 2q21-q23 [1]. In 2001, two groups independently discovered the cause of MWS as mutation or deletion of the ZEB2 gene (MIM# 605802) from studies of two de novo translocations and demonstrated intragenic truncating mutations in several other individuals affected by the disease [2,3].
###end p 6
###begin title 7
Epidemiology
###end title 7
###begin p 8
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 216 224 <span type="species:ncbi:9606">patients</span>
The prevalence of MWS is currently unknown, but it seems probable that the syndrome is under-diagnosed, particularly in patients without HSCR [4]. Since the first delineation by Mowat et al (1998), approximately 171 patients with ZEB2 mutations, deletions or cytogenetic abnormalities have been reported primarily from Northern Europe, Australia, Italy and the United States, and over 100 mutations have been described [2-31]. The male/female ratio is approximately 1,42:1 [19,22,24,29-31]. The syndrome has been identified in several ethnic groups [22], with similar clinical features in all populations.
###end p 8
###begin title 9
Clinical description
###end title 9
###begin p 10
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Clinical manifestations of the MWS are presented in Table 1.
###end p 10
###begin p 11
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Mowat-Wilson Syndrome: Clinical features in patients with ZEB2 mutations [1-31].
###end p 11
###begin title 12
Facial gestalt
###end title 12
###begin p 13
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
The clinical features of the face are very typical and the diagnosis of MWS is based on recognition of the distinctive facial gestalt, usually associated with severe mental retardation. This phenotype, which changes with age, typically prompts the clinician to consider the diagnosis (Figures 1, 2, 3).
###end p 13
###begin p 14
###xml 44 54 44 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 1 </italic>
###xml 44 51 <span type="species:ncbi:9606">Patient</span>
Mowat-Wilson Syndrome, clinical features of Patient 1 at age: (A) 1 year and 6 months; (B-C) 5 years; (D-E) 13 years and 8 months; (F-G) 18 years.
###end p 14
###begin p 15
###xml 44 54 44 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patient 2 </italic>
###xml 44 51 <span type="species:ncbi:9606">Patient</span>
Mowat-Wilson Syndrome, clinical features of Patient 2 at age: (A) 1 year and 6 months; (B-C) 3 years and 5 months; (D-E) 8 years and 1 month.
###end p 15
###begin p 16
###xml 44 61 44 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patients 3 and 4 </italic>
###xml 69 81 69 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patients 3: </italic>
###xml 157 169 157 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patients 4: </italic>
###xml 44 52 <span type="species:ncbi:9606">Patients</span>
###xml 69 77 <span type="species:ncbi:9606">Patients</span>
###xml 157 165 <span type="species:ncbi:9606">Patients</span>
Mowat-Wilson Syndrome, clinical features of Patients 3 and 4 at age: Patients 3: (A) 1 year and 2 months; (B) 3 years and 4 months; (C) 8 years and 1 month; Patients 4: (D) 3 years; (E) 3 years; (F) 3 years and 6 months.
###end p 16
###begin p 17
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 744 745 744 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
In infancy, there are excess nuchal skin, a rounded skull shape, a sparse fine hair and a puffy anterior neck; the face is square shaped with high forehead, frontal bossing, hypertelorism, strabismus, epicanthus, deep set but large eyes, a broad nasal bridge, saddle nose with prominent rounded nasal tip, prominent columella, open mouth, with M-shaped upper lip, frequent smiling, and a prominent but narrow and triangular pointed chin. Additional suggestive facial features include telecanthus, a full or everted lower lip and posteriorly rotated ears. The more consistent and easily recognisable features are the eyebrows, which are large, medially flaring and sparse in the middle part and the ear lobes, which are very typical (Figures 4, 5). They are large and uplifted with a central depression and have been described as being like "orecchiette pasta" or like "red blood corpuscles" in shape.
###end p 17
###begin p 18
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Main common features of the patients with Mowat-Wilson Syndrome: uplifted ear lobes as "orecchiette pasta" or "red blood corpuscles".
###end p 18
###begin p 19
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Main common features of the patients with Mowat-Wilson Syndrome: large eyebrows, medially flaring and sparse in the middle part.
###end p 19
###begin p 20
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 77 85 <span type="species:ncbi:9606">children</span>
The facial phenotype of MWS is quite distinct and changes with age: in older children the eyebrows become heavier, broad and horizontal, with an increased wide middle separation and medial sparseness [10,19,22]. The nasal tip lengthens and becomes more depressed, the columella is more prominent, leading to the appearance of a short philtrum, the nasal profile becomes convex, the face tends to elongate and the jaw is more pronounced.
###end p 20
###begin p 21
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
In adolescents, the nasal tip overhangs the philtrum, the face becomes long with prognathism, and a long, pointed or "chisel-shaped" chin [10,19,22]. The uplifted ear lobes do not change significantly with time (with the exception of the central depression, which is less obvious in adults) and are an excellent diagnostic clue.
###end p 21
###begin title 22
Growth
###end title 22
###begin p 23
###xml 134 136 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th</sup>
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th</sup>
###xml 181 183 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th</sup>
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">rd</sup>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 679 681 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 758 761 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">rd </sup>
###xml 771 774 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 465 473 <span type="species:ncbi:9606">children</span>
At birth, growth parameters are usually in the normal range, including head circumference. The mean birth weight at term is 3370 g (25th-50thcentile), the mean length is 50.9 cm (50th-75th centile) and the mean head circumference is 33 cm (3rd-10th centile). The cranial circumference at birth is, in general, one centile less than that of weight and length [12]. Microcephaly is sometimes present at birth, but more often develops gradually in infancy and not all children are microcephalic (at or below 2SD below the mean). Microcephaly is a common but not constant feature and was present in 135 out of 166 of the published cases describing this clinical sign (81%) [19,22,24,29-31]. In the other individuals the head circumference was often between the 3rd and the 10th centile.
###end p 23
###begin p 24
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
Most patients are of slender build. Postnatal short stature is usual (34 out of 73 of the published cases with available information: 46%), but several patients have normal stature.
###end p 24
###begin p 25
Information regarding pubertal development in subjects with MWS is, at the moment, limited.
###end p 25
###begin title 26
Neurologic findings and behavior
###end title 26
###begin p 27
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 472 480 <span type="species:ncbi:9606">patients</span>
MWS patients have at least moderate but usually severe mental retardation. Hypotonia is frequent in the first years of life; it was present in 45 out of 48 of the published cases (93%) with available information. Developmental milestones such as sitting and walking are very delayed (mean age of sitting without support is 20 months, and mean age of walking is 4 years and 3 months (range: 23 months to eight years), though some remain non-ambulatory [5,9-12,18,19]. Some patients were noted to have a wide-based or ataxic-like gait, sometimes they held their arms up and flexed at the elbow, reminiscent of individuals with Angelman syndrome [9,19]. Fine motor skills are delayed. The oldest individuals (aged over 20 years) are able to drink from a cup, but need assistance with dressing and activities of daily living [19].
###end p 27
###begin p 28
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
Speech is typically limited to a few words, with onset at around 5-6 years. Some patients do not speak at all. However, reports in the genetic literature, along with anecdotal reports from families and educators, suggest that many patients have receptive language skills and communicate successfully using alternative methods, like sign language [9,10,19].
###end p 28
###begin p 29
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 205 213 <span type="species:ncbi:9606">children</span>
Most subjects have a happy demeanour with frequent smiling and a happy, affectionate, and sociable personality [9,11,12,19]. Some patients have stereotypes with repeated movements of hands and head, other children are fascinated by turning the pages of books and magazines [19].
###end p 29
###begin p 30
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Seizures or abnormal electroencephalogram (EEG) are described in 102 out of 139 of the published cases (73%) [19,22,24,29-31], although no particular seizure type is characteristic of the condition. The seizures are variable in nature, from absences to generalized seizures and myoclonic seizures [9,19]. Onset of seizures usually occurs in the second year of life, but seizures may begin in the neonatal period, in infancy or in late childhood, or at over ten years of age [9,10,19]. In some cases, the seizures are resistant to treatment in childhood, but appear to be more easily managed in adolescents and adults [9].
###end p 30
###begin p 31
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Brain anomalies reported so far include hypoplasia or agenesis of corpus callosum, which was present in 67 out of 155 of the published cases (43%) [19,22,24,29-31], ventriculomegaly [19], cortical atrophy [6,20,25], pachygyria and cerebellar hypoplasia [30,31], poor hippocampal formation [13] and frontotemporal hypoplasia with temporal dysplasia [3,9]. These findings may be under-represented because not all published cases underwent cranial imaging.
###end p 31
###begin title 32
Hirschsprung disease
###end title 32
###begin p 33
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Hirschsprung disease was present in 97 out of 170 of the published cases (57%) [19,22,24,29,31].
###end p 33
###begin p 34
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
Many patients without known HSCR have been noted to have severe constipation, not investigated by rectal biopsy. Constipation was in fact present in 19 out of 73 of the published cases without HSCR (26%) [19,22,29]. A milder form of HSCR might not be diagnosed in infancy.
###end p 34
###begin p 35
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 152 160 <span type="species:ncbi:9606">Patients</span>
The data on the length of the aganglionic segment is incomplete in published cases, but short and long segments are both reported in males and females. Patients with ZEB2 deletion, but not those with mutations, tend to develop aganglionosis affecting longer segments [32]. This variety in the severity of HSCR in MWS may be caused by both variations in ZEB2 abnormalities and epigenetic factors [32].
###end p 35
###begin p 36
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
It is probable that MWS is under-diagnosed in patients without HSCR and it has been well documented that this feature is not always present [4,5,7-12,19,22,24,25]. In the largest series of 57 cases, the frequency of HSCR was 46%, suggesting that with increasing clinical experience the diagnosis can be made with and without HSCR [22].
###end p 36
###begin title 37
Other oropharyngeal and gastrointestinal findings
###end title 37
###begin p 38
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 737 742 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 400 407 <span type="species:ncbi:9606">patient</span>
###xml 555 562 <span type="species:ncbi:9606">patient</span>
Other gastrointestinal anomalies, such as pyloric stenosis (one in case with a family history of pyloric stenosis) have been reported in eight patients [2,7,9,10,19,22,25]. A highly arched palate is often present, possibly secondary to hypotonia [9]. Submucous cleft, cleft soft palate, cleft hard palate, and bilateral cleft lip and palate have been described by some authors [1,3,9,10,20,22,25]. A patient with velopharyngeal insufficiency with laryngomalacia, glossoptosis and micrognathia, as opposed to a prominent chin has been described [19]. This patient had a large deletion encompassing the ZEB2 gene, and therefore, it is unclear whether these additional findings may be related to haploinsufficiency of genes surrounding the ZEB2 locus [19].
###end p 38
###begin title 39
Congenital heart disease
###end title 39
###begin p 40
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Congenital heart disease was demonstrated in 87 out of 167 (52%) of the published cases [19,22,24,29-31].
###end p 40
###begin p 41
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 115 123 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
###xml 324 331 <span type="species:ncbi:9606">patient</span>
###xml 374 381 <span type="species:ncbi:9606">patient</span>
###xml 412 419 <span type="species:ncbi:9606">patient</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
###xml 480 487 <span type="species:ncbi:9606">patient</span>
###xml 517 524 <span type="species:ncbi:9606">patient</span>
###xml 546 553 <span type="species:ncbi:9606">patient</span>
###xml 584 591 <span type="species:ncbi:9606">patient</span>
The wide spectrum of heart defects observed include patent ductus arteriosus (16 patients), pulmonary stenosis (12 patients) and ventricular septal defect (12 patients), which are the most common, atrial septal defect (8 patients), pulmonary artery sling (6 patients), Tetralogy of Fallot (5 patients), pulmonary atresia (1 patient), peripheral pulmonary artery stenosis (1 patient), missing pulmonary artery (1 patient), aortic coarctation (4 patients), bicuspid aortic valve (1 patient), interrupted aortic arch (1 patient), mitral prolapse (1 patient) and aortic valve stenosis (1 patient) [1,5,7-14,17-19,22,25].
###end p 41
###begin p 42
Structural heart defects are variable, but seem to frequently involve the pulmonary arteries and/or valves.
###end p 42
###begin p 43
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 5 13 <span type="species:ncbi:9606">patients</span>
###xml 174 181 <span type="species:ncbi:9606">patient</span>
Five patients have been reported with a rare, unusual congenital heart disease, pulmonary artery sling, two of whom also had tracheal stenosis/hypoplasia [18,19,25]. Another patient had tracheal stenosis with aortic valvular stenosis [22]. In 2007, Dastot-Le Moal suggested that pulmonary artery sling with or without tracheal stenosis may be a particular association of MWS and should prompt the clinician to consider this diagnosis [22].
###end p 43
###begin title 44
Genitourinary
###end title 44
###begin p 45
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Urogenital/renal anomalies were demonstrated in 81 out of 156 of the published cases (51%) [19,22,24,29-31].
###end p 45
###begin p 46
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
###xml 549 556 <span type="species:ncbi:9606">patient</span>
In 63 out of 100 males with MWS for whom this information was available, 58 had genital anomalies, and hypospadias was present in 33/63 patients (52%). This frequency is high for a single anomaly within a multiple congenital anomalies/mental retardation syndrome, where clinical signs can be variably present. From the analysis of EUROCAT data, hypospadias affects about 3 per 1000 male births [33]. Cryptorchidism was described in 36% of patients (23/63), bifid scrotum and webbed penis were identified in 3 out of 63 cases, and micro-phallus in 1 patient. Eight out of 63 males with genitalia anomalies, have both hypospadias and cryptorchidism [5,7,9,12,16-20,24,25,32]. Only one female with MWS had genital anomalies, consisting of a vaginal septum [25].
###end p 46
###begin p 47
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 33 41 <span type="species:ncbi:9606">children</span>
###xml 77 84 <span type="species:ncbi:9606">patient</span>
###xml 108 115 <span type="species:ncbi:9606">patient</span>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
Other genitourinary anomalies in children with MWS included duplex kidney (1 patient) [1], pelvic kidney (1 patient) [9], vesicoureteric reflux (10 patients) [7,9,10,13,19,22,24] and hydronephrosis (8 patients) [7,10,12,13,18,19].
###end p 47
###begin title 48
Musculoskeletal
###end title 48
###begin p 49
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 865 867 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">st</sup>
###xml 869 872 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 1196 1199 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 1213 1216 1213 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">st </sup>
###xml 1221 1224 1221 1224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">rd </sup>
###xml 1230 1231 1230 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1232 1233 1232 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1234 1235 1234 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1236 1237 1236 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1238 1240 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1253 1255 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Musculoskeletal anomalies occur in many patients. Most individuals are of slender build. In childhood they are described as having slender and tapering fingers, sometimes with prominent fingertip pads, with prominence of the interphalangeal joints developing in later childhood, adolescence and adulthood [9,12,19,34]. The feet have been described as having pes planus, mild calcaneovalgus deformity and long toes [9,12,19,34]. The following features have been reported in at least one affected subject: wormian bones, pectus excavatum, pectus carinatum, superior pectus carinatum/inferior pectus excavatum, scoliosis, genu valgus, recurrent non-traumatic patellar dislocation, mild contractures of the hip, elbows and knees, ulnar deviation of the hands, radial deviation of the thumbs, short broad thumbs, proximally placed thumbs, adducted thumbs (positional), 1st-2nd finger syndactyly, distal phalanges of fingers hypoplasia, camptodactyly, delayed bone age, broad halluces, long halluces, hallux valgus, unilateral duplication of the hallux, hypoplasia of halluces, hypertrophic first ray of the feet, middle and distal phalanges hypoplasia of toes, brachytelephalangia, overriding of the 2nd toe over the 1st and 3rd toes [1-3,6,9-11,16,19,20,22,34].
###end p 49
###begin title 50
Eye defects
###end title 50
###begin p 51
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 383 388 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 333 340 <span type="species:ncbi:9606">patient</span>
Eye structural anomalies have only recently been reported in association with MWS and were described in 7 out of 170 of the published cases (4,1%) [18,22]; three had microphthalmia (one of whom with in addition iris coloboma and cataract), three h ad iris/retinal/optic disc colobomas, and one Axenfeld anomaly [17-19,22,28,34]. One patient with coloboma and high myopia had a novel ZEB2 missense mutation and trisomy 21 [28]. These eye findings are consistent with the expression of the gene in the developing eye [18].
###end p 51
###begin p 52
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Strabismus, although quite rarely mentioned, was also evident in many photographs and appears to be frequent. Nystagmus due to fixation difficulties is frequently described in infancy, but tends to resolve with age [9,34].
###end p 52
###begin p 53
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
The following features have been reported in at least one affected subject: ptosis, myopia, astigmatism, dark pigment clumps in blue irises, described as irides heterochromia by some authors [9,12,34].
###end p 53
###begin p 54
A pediatric ophthalmologic evaluation should therefore be performed in any individual with MWS.
###end p 54
###begin title 55
Hearing function
###end title 55
###begin p 56
###xml 221 222 221 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 133 141 <span type="species:ncbi:9606">children</span>
###xml 285 293 <span type="species:ncbi:9606">children</span>
###xml 334 342 <span type="species:ncbi:9606">patients</span>
Recurrent episodes of otitis media have been described in patients with MWS. Hearing loss was not found in patients tested, although children with recurrent or chronic otitis media are at risk of conductive hearing loss [9,19,34]. An audiological evaluation should be performed in all children with language impairment, including MWS patients [19,34].
###end p 56
###begin title 57
Teeth anomalies
###end title 57
###begin p 58
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
There is limited available information regarding the dental characteristics of patients with MWS. The following features have been reported in at least one affected subject: widely spaced teeth, dental crowding, "malpositioned" teeth, delayed tooth eruption [19,34].
###end p 58
###begin title 59
Skin
###end title 59
###begin p 60
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
One patient with MWS has been described as having gradual onset of widespread "raindrop" depigmentation on the trunk [9,10]. Depigmentation was otherwise reported in two other subjects [3,22]. Dermatoglyphic anomalies/deep palmar and plantar creases have been described in at least eight patients [6,12]. Three subjects have been found to have accessory nipples [19]. Preauricular tag was reported in one individual [1].
###end p 60
###begin title 61
Other clinical features
###end title 61
###begin p 62
###xml 35 37 35 37 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 4 11 <span type="species:ncbi:9606">patient</span>
One patient with MWS had asplenia [18]. Another one had autonomic dysregulation (later onset) [3,22]. Repeated vomiting attacks, suggestive of epilepsy, were observed in five cases [25].
###end p 62
###begin title 63
Etiology
###end title 63
###begin p 64
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 157 163 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
MWS is caused by an heterozygous mutation in the ZEB2 gene (OMIM# 605802) [35] that was identified by Wakamatsu et al and Cacheux et al in 2001 [2,3]. Mowat et al described the syndrome in 1998 and also identified a locus at chromosome 2q21-q23 [1].
###end p 64
###begin p 65
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 366 371 <span type="species:ncbi:9606">human</span>
The ZEB2 gene spans approximately 70 Kb, consists of 10 exons and 9 introns (Figure 6), and encodes for SIP1 (Smad interacting protein 1, SMADIP1) [2]. The initiation codon is located in exon 2 and the stop codon is in exon 10. SIP1 is a zinc finger/homeodomain transcriptional repressor and consists of 1214 amino acids [36-39]; ZEB2 mRNA is detected in nearly all human tissues [3,8,40,41].
###end p 65
###begin p 66
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
Scheme of ZEB2 exons and corresponding protein structure adapted from Zweier et al [4], showing the position of the presented mutations. NZF, N-terminal zinc finger cluster; CZF, C-terminal zinc finger cluster; SBD, Smad binding domain; HD, homeodomain like segment. [5, 11, 15, 17, 28].
###end p 66
###begin p 67
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
Clinical features suggest that the ZEB2 gene is involved in the development of neural-crest derived cells (enteric nervous system, craniofacial mesectoderm), central nervous system, heart septation (patent ductus arteriosus, ventricular and atrial septal defect) and midline development (corpus callosum agenesis, genitourinary anomalies and pyloric stenosis) [5,7,25]. Comparison of the human and mouse homologues of ZEB2 at the nucleotide and amino acid levels revealed 93% and 97% similarities, respectively [2,3].
###end p 67
###begin p 68
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2</italic>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
To date, 171 patients have been published [4,9-12,18,19,22,24,29-31]. In all of these patients, heterozygous mutations of the zinc finger E-box-binding homeobox 2 gene (ZEB2) were detected. In most cases the mutation produces an absent or truncating protein [9] which loses its function.
###end p 68
###begin p 69
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The most frequent mutations are: frameshift mutations (small insertions and deletions that lead to truncating frameshift mutations) (41,5%) [2,3,5-8,10,17-19,22,23,25], non-sense mutations (31,6%) [2,5,7,8,10,12,18,22,24,25], and deletions (not detectable by standard cytogenetic method) (19,3%) [2,7,11,18,19,22,24,25,29,31]. Rare mutations have been reported: cytogenetically detectable deletions (1,2%) [1,14], translocation (0,6%) disrupting the disease-gene [3], splice site mutations (2,3%) [10,18,21], missense mutations (1,7%) [20,22,28], complex mutations (combination of deletion and insertion) (1,2%) [22,25] and an inframe mutation (0,6%) [27].
###end p 69
###begin p 70
###xml 43 44 43 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
The mutations cover all the coding region [9], and are more frequent in exon 8 (69 cases, 51,1%) [22]. Four recurrent mutations have been observed: 2083C > T (13, exon 8), 2761C > T (5, exon 8) 1027C > T (4, exon 8) and 904C > T (3, exon 7) [8,18,22].
###end p 70
###begin p 71
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
As two patients with non-sense mutations were reported to have the same severe phenotype that those found in patients with large 2q22 deletions, it has been pointed out that MWS is not a contiguous gene syndrome, and that truncating mutations of one allele of the ZEB2 gene are sufficient to result in this complex phenotype [12].
###end p 71
###begin p 72
###xml 57 58 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
Haploinsufficiency is probably the underlying mechanism [7-11,18,22,42].
###end p 72
###begin p 73
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 134 141 <span type="species:ncbi:9606">patient</span>
Few studies on polymorphisms have been carried out. The amino acid altering change p.Pro714Leu, localized in exon 8, was found in one patient (in addition to a non-sense mutation) and in his healthy father, but was not detected in 96 normal controls [18].
###end p 73
###begin p 74
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 602 607 602 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 61 68 <span type="species:ncbi:9606">patient</span>
###xml 322 330 <span type="species:ncbi:9606">children</span>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
###xml 561 568 <span type="species:ncbi:9606">patient</span>
The silent alteration p.Ile163Ile was identified both in one patient and in his father [18]. The small number of polymorphisms indicates that ZEB2 sequence is under strong evolutionary constraint and even small variations compromise the protein function [18]. A recent study on polymorphisms by Dastot et al, 2007, in 180 children (120 unaffected and 60 MWS patients) showed 20% polymorphism in exon 7 (transition T4C in intron 7 (c.917-21T4C) in both groups. The authors identified an amino acid change in exon 10 (amino acid change p.Glu1094Lys) in a typical patient who also had a total deletion of ZEB2 on the other chromosome. As this alteration was also identified in the healthy mother, it was probably a polymorphism [22].
###end p 74
###begin p 75
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
In two cases of typical MWS, the mutation was not identified [10]. It could be due to the presence of mutations not detectable by mutational screening, or it could also indicate genetic heterogeneity for this clinical syndrome [10].
###end p 75
###begin title 76
Genotype-phenotype correlation
###end title 76
###begin p 77
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 171 179 <span type="species:ncbi:9606">Patients</span>
The studies on genotype-phenotype analysis show that in most cases the phenotype was similar in patients with deletions and in those with truncating mutations [11,12,18]. Patients with large deletions may have a more severe phenotype and additional features [11,25,30,31]. Facial gestalt and the psychomotor development delay, particularly of language, are constant. The frequent and severe malformations (HSCR, congenital heart defect, agenesis of the corpus callosum) and seizures may lead to suspicion of the diagnosis, but their presence is variable [5,9,12,17,18,22].
###end p 77
###begin p 78
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 151 159 <span type="species:ncbi:9606">patients</span>
The comparison between clinical data concerning the associated malformations of one of the patients with a R695X mutation and those of the other eight patients with the same mutation, demonstrated the phenotypic variability of a single mutation in MWS [4,12]. This variability is remarkable not only in the same mutation but also in the same family. In fact, two siblings (sister and brother) with characteristic face, HSCR and agenesis of the corpus callosum were discordant for congenital heart disease and ocular coloboma [17]. On the other hand, the phenotypic expression in two affected sisters was very similar for a/hypoplasia of corpus callosum, HSCR, congenital heart defect, seizures and microcephaly [18]. These features might be controlled by common familial genetic modifiers [18].
###end p 78
###begin p 79
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 128 136 <span type="species:ncbi:9606">patients</span>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 323 330 <span type="species:ncbi:9606">patient</span>
Few data are available about the parental origin of deletions. The origin of the deleted chromosome is paternal in 17 out of 19 patients examined so far [11,22,25,42]. The investigation of four patients showed that agenesis of corpus callosum (present in two patients and absent in two others) and seizures (present in one patient and absent in three others) showed no correlation with paternal origin of the deletion [11].
###end p 79
###begin p 80
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
HSCR, when present, is a strong cross reference marker, even in the neonatal period, but it is not constant. It is noteworthy that at first the patients were selected among those with syndromic HSCR. As the number of described patients with ZEB2 mutations rises, the percentage of patients with HSCR decreases: 70% of 30 patients [11], 62% of 45 [9], 63.8% of 47 [12], 62.8% of 70 [4], 62,6% of 97 [18], 57.2% of 159 [22] and 57% of 170. Therefore, there was a bias of ascertainment.
###end p 80
###begin p 81
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
Also the male preponderance of HSCR in general populations (4:1) [43] can cause a bias of ascertainment and explain the male excess in MWS [9]. In fact, the male/female ratio decreases from 2.13/1 out of 47 patients (M/F 32/15) [12] to 1.92/1 out of 70 patients (M/F 46/24) [4], to 1.49/1 out of 97 patients (M/F 58/39) (personal data), to 1.37/1 out of 159 patients (M/F 92/67) [22] and today 1.42/1 out of 170 patients (M/F 100/70).
###end p 81
###begin p 82
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zfhx1b </italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
The manifestation of HSCR is not influenced by deletion size [11]. Moreover, Zfhx1b knockout mice do not exhibit HSCR [44], therefore a non-allelic modifier might contribute to the manifestation of HSCR [11].
###end p 82
###begin p 83
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 63 69 <span type="species:ncbi:9606">person</span>
###xml 97 102 <span type="species:ncbi:9606">woman</span>
Unusual mutations can lead to an atypical phenotype. The first person reported was a 48-year-old woman with severe constipation and mild mental retardation in the absence of specific facial anomalies, seizures, and other malformations caused by non-truncating mutations with a 3 bp in frame deletion [27].
###end p 83
###begin p 84
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
###xml 112 115 <span type="species:ncbi:9606">boy</span>
###xml 285 290 <span type="species:ncbi:9606">child</span>
Three patients with ZEB2 missense mutations showed a clinical severity as variable as expected. The first was a boy with Down syndrome and typical facial features of trisomy 21, HSCR (rarer in Down syndrome than in MWS), myopia, and ocular coloboma affecting iris and retina [28]. The child showed some dysmorphism compatible with MWS but not the facial gestalt. The importance of ocular anomalies that differs and are more severe than those observed in Down syndrome is underlined.
###end p 84
###begin p 85
###xml 38 40 38 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 8 11 <span type="species:ncbi:9606">boy</span>
Another boy with a missense mutation [20] showed HSCR, corpus callosum hypoplasia, epilepsy and severe mental retardation, but also other anomalies such as cleft lip and palate, brachytelephalangy, and broad thumbs and halluces. Facial phenotype was similar to MWS but differed by the presence of bilateral cleft lip and palate, and eyebrows that were not typical of MWS.
###end p 85
###begin p 86
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 49 54 <span type="species:ncbi:9606">child</span>
The third missense mutation was found in a young child with typical MWS including HSCR who died at age of 3 years [22].
###end p 86
###begin p 87
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 150 155 <span type="species:ncbi:9606">child</span>
###xml 801 809 <span type="species:ncbi:9606">patients</span>
An exceptionally mild phenotype, caused by a novel and unusual splice site mutation in the 5'UTR, was reported by Zweier et al (2006) in a 5-year-old child. He showed a mild motor and speech delay but, by age 5 years, he spoke in full sentences. The phenotype was not typical but facial features resembled the facial gestalt of MWS. Clinical features were mild in comparison with these associated with truncating mutations, no malformations or seizures were present. The mild phenotype could be due to the conservation of all known functional domains of the protein: in fact, this mutation only results in loss of exon 2 [21]. The authors suggested that exon 2 might contain important determinants of the facial phenotype in MWS [21]. Three other splice site mutations [10,18] have been identified in patients with typical phenotypes.
###end p 87
###begin p 88
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
The confirmation of the diagnosis based on the presence of a mutation, deletion or translocation in the ZEB2 gene will allow the knowledge on genotype-phenotype correlation to be increased.
###end p 88
###begin title 89
Diagnostic methods
###end title 89
###begin p 90
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
###xml 495 503 <span type="species:ncbi:9606">patients</span>
###xml 527 534 <span type="species:ncbi:9606">patient</span>
Diagnosis may be suspected on the basis of the clinical phenotype in typical patients. Facial gestalt is particularly important. Serious malformations (HSCR, heart disease, agenesis of corpus callosum) are common even if not always present. Seizures are frequent and psychomotor delay, particularly serious in spoken language, is constant. A small number of patients with rare mutations (inframe, missense and splice site mutations) may show an atypical clinical picture (until now, 2.4% of the patients: 4/169). In all cases, patient should undergo molecular analysis of the ZEB2 gene.
###end p 90
###begin p 91
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
A cytogenetic analysis should be carried out to exclude large deletions or translocations. FISH analysis enables submicroscopic deletions to be detected. Sequencing of the complete coding sequence of ZEB2 identifies the mutations [5,9,22]. The semi-quantitative fluorescent multiplex polymerase chain reaction (PCR) assay allows detection of other rearrangements that escaped conventional methods [22]. Sequence analysis detects mutations in approximately 79% of affected individuals, FISH analysis detects deletions in 13%, chromosomal rearrangements cause MWS in 2% and an additional 6% have an intermediate-sized deletion detected by quantitative PCR or multiplex ligation-dependent probe amplification (MLPA) [34].
###end p 91
###begin p 92
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 5 12 <span type="species:ncbi:9606">patient</span>
###xml 241 248 <span type="species:ncbi:9606">patient</span>
###xml 266 270 <span type="species:ncbi:9606">girl</span>
In a patient with multiple congenital anomalies and an apparently balanced translocation involving chromosomes 2, 3 and 5, 1 Mb resolution array-CGH detected a cryptic deletion of about 6 Mb of chromosome 2 including the ZEB2 gene [29]. The patient, a six-month-old girl, had dysmorphic features typical of MWS, microcephaly and severe psychomotor retardation.
###end p 92
###begin title 93
Differential diagnosis
###end title 93
###begin p 94
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 586 591 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
###xml 599 606 <span type="species:ncbi:9606">patient</span>
The facial features of patients with MWS are quite characteristic, but the presence of HSCR, epilepsy and mental retardation may initially suggest Goldberg-Shprintzen syndrome (GOSHS) [5]. The patients with GOSHS (actually MIM 609460) share clinical features such as HSCR, epilepsy and mental retardation, but have a different facial gestalt (high nasal bridge, synophrys, long curled eyelashes, palpebral ptosis, and cleft palate are commonly observed) [45,46]. The differential diagnosis can be carried out on the basis of facial phenotype and confirmed by mutational analysis of the ZEB2 gene. A patient with short segment HSCR, microcephaly, mental retardation, and distinct facial appearance in the absence of ZEB2 intragenic mutations was diagnosed as GOSHS [30]. Further molecular studies showed a deletion of the 2q22-q23 region encompassing the ZEB2 gene [31].
###end p 94
###begin p 95
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 114 123 114 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K1AA1279 </italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
In five patients with GOSHS in a consanguineous Moroccan family, Brooks et al identified a homozygous mutation in K1AA1279 at 10q22.1 [47]. Today, it is possible to carry out molecular analyses for both syndromes.
###end p 95
###begin p 96
The differential diagnosis is important for genetic counseling, since GOSHS is autosomal recessive, whereas MWS is a sporadic condition.
###end p 96
###begin p 97
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RET </italic>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EDNRB </italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
ZEB2 mutation analysis may be also considered in patients with syndromic [43] and apparently non-syndromic HSCR disease and no mutation in other related genes such as RET or EDNRB [20,48,49].
###end p 97
###begin p 98
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Individuals with MWS have often been described as having a wide-based or ataxic-like gait, and a smiling, happy and sociable personality. This, combined with absent speech, microcephaly and seizures, has led some individuals to be given a presumptive diagnosis of Angelman syndrome [19]. However, the facial features of MWS, in addition to the other typical congenital anomalies, distinguish these two conditions.
###end p 98
###begin p 99
###xml 3 11 <span type="species:ncbi:9606">patients</span>
In patients with hypospadias and mental retardation it is necessary to take into account the differential diagnosis with Smith-Lemli-Opitz syndrome, Opitz G/BBB syndrome and X-linked mental retardation-alpha thalassemia syndrome. However, the gestalt of MWS is different.
###end p 99
###begin title 100
Genetic counseling
###end title 100
###begin p 101
###xml 16 24 <span type="species:ncbi:9606">patients</span>
The majority of patients with MWS so far reported are sporadic cases; therefore the recurrence risk is low. Nevertheless, cases of sibling recurrence have been observed.
###end p 101
###begin p 102
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
Two sisters with MWS born to healthy parents have been reported. Mutation analysis of both parents revealed a low paternal mosaicism. The father had short stature (150 cm, Vietnamese origin), somewhat uplifted earlobes and a pointed nasal tip [18].
###end p 102
###begin p 103
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
Another recurrence was found in a brother and a sister with clinical features of MWS and the same truncating mutation in exon 8. The parents were phenotypically normal, without mutation in the ZEB2 gene. Thus, the most likely explanation is germ-line mosaicism [17].
###end p 103
###begin p 104
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Recently, another family with three affected sibs has been reported [[34] by D. Mowat, personal communication]. Therefore, the recurrence risk, on the basis of the current data, is 3/170 families (1.76%) [17,18,34].
###end p 104
###begin p 105
###xml 148 153 <span type="species:ncbi:9606">child</span>
In the case of a balanced familial translocation, the risk is higher. Karyotype and gene analysis should be offered to the parents with an affected child and, in these cases, prenatal diagnosis is possible.
###end p 105
###begin title 106
Antenatal diagnosis
###end title 106
###begin p 107
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
There are few data concerning specific prenatal markers suitable during pregnancy. Wilson et al (2003) reported increased nuchal translucency in two patients [10].
###end p 107
###begin p 108
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZEB2 </italic>
Since agenesis of the corpus callosum is the only MWS feature that can be detected prenatally, molecular screening of the ZEB2 gene in prenatal isolated agenesis of the corpus callosum, has been carried out [50]. No gene mutations were detected in six fetuses. It has been concluded that ZEB2 is not the major gene for isolated agenesis of the corpus callosum and that a particular attention to the facial features (dysplastic ears) at ultrasound or fetopathological examination may help the diagnosis of MWS in fetuses with agenesis of the corpus callosum.
###end p 108
###begin p 109
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 83 91 <span type="species:ncbi:9606">children</span>
###xml 124 129 <span type="species:ncbi:9606">child</span>
###xml 696 701 <span type="species:ncbi:9606">child</span>
Only one case of examinations in pregnancy has been performed in a family with two children affected by MWS [17]. The first child, a female, had HSCR, dysmorphic features and developmental delay. The cerebral magnetic resonance imaging (MRI) showed agenesis of the corpus callosum but the karyotype analysis was normal; thus, diagnosis was not made. On the second pregnancy, a nuchal translucency scan was reported as normal, but both fetal ultrasound and MRI examination showed agenesis of the corpus callosum. Amniocentesis demonstrated a normal male karyotype [17]. MRI examination of the mother showed a normal corpus callosum. It could be supposed that the absence of diagnosis on the first child did not allow a correlation of agenesis of corpus callosum with the recurrence of a syndrome.
###end p 109
###begin p 110
Other observations and studies are necessary to increase the knowledge and identify possible prenatal markers.
###end p 110
###begin title 111
Management
###end title 111
###begin p 112
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
There is no specific treatment for MWS, as the neural defect and also other malformations resulting from the mutation occur in the early stage of embryonal development [41].
###end p 112
###begin p 113
###xml 318 326 <span type="species:ncbi:9606">patients</span>
The frequent presence of serious congenital malformations requires precocious clinical investigation with intervention of neonatologists, pediatricians and several specialists. Congenital heart disease and HSCR requires early surgery at the first days or months of life. Serious constipation also persists in operated patients.
###end p 113
###begin p 114
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 158 165 <span type="species:ncbi:9606">patient</span>
Seizures can begin in the first months of life and require suitable therapies; however, in two of our patients the seizures were fairly quickly resolved. One patient still has seizures at the age of 9 years, while the other, at the age of six, had never suffered them.
###end p 114
###begin p 115
Genitourinary anomalies such as hypospadias, cryptorchidism, bifid scrotum, vesicoureteral reflux and hydronephrosis may be present in the first years of life and may require surgery.
###end p 115
###begin p 116
Eye problems are frequent and require a specialized help.
###end p 116
###begin p 117
###xml 109 117 <span type="species:ncbi:9606">children</span>
Deafness has not been reported. Nevertheless, speech retardation requires audiometric examination of all MWS children.
###end p 117
###begin p 118
All advised vaccinations are recommended.
###end p 118
###begin p 119
A periodic follow-up for the different clinical problems should be carried out regularly.
###end p 119
###begin p 120
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Psychomotor development is retarded in all patients, therefore rehabilitation including physical therapy, psychomotor and speech therapy should be started as soon as possible.
###end p 120
###begin title 121
Prognosis
###end title 121
###begin p 122
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 116 123 <span type="species:ncbi:9606">patient</span>
###xml 194 201 <span type="species:ncbi:9606">patient</span>
###xml 285 292 <span type="species:ncbi:9606">patient</span>
There are few data about survival of the patients affected by MWS. We are aware of the death of three patients. One patient with a large deletion and seizures in the neonatal period [11], and a patient with aortic valvular stenosis [22] both died in the first month of life. The third patient, having a missense mutation, died at 3 years of age [22].
###end p 122
###begin p 123
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 30 37 <span type="species:ncbi:9606">patient</span>
As far as we know, the oldest patient reported so far is 30-years-old [25].
###end p 123
###begin p 124
Early molecular diagnosis is feasible today and is of great importance in order to start the therapeutic and rehabilitation treatment as soon as possible.
###end p 124
###begin p 125
The diagnosis of MWS is important also for the family, regardless of the prognosis. In fact, the diagnosis permits caregivers to give information and psychological support, and relieves the families from a profound sensation of solitude.
###end p 125
###begin p 126
###xml 221 229 <span type="species:ncbi:9606">patients</span>
The increase of knowledge on the syndrome will support the educational and rehabilitation aid by parents and caregivers, and help the achievement of improvements in the psychomotor development and the autonomy of the MWS patients.
###end p 126
###begin p 127
The support resulting from Family Associations is also important.
###end p 127
###begin title 128
Acknowledgements
###end title 128
###begin p 129
The authors wish to thank the Reviewers for their positive remarks and useful suggestions. They also wish to thank the research assistants Enrico Albertini, Chiara Castronovo, Elena Favaron, Francesca Rivieri, Fiorenza Soli and Michela Zignani for their collaboration, and Fondazione Cassa di Risparmio di Vercelli for its support.
###end p 129
###begin p 130
###xml 143 151 <span type="species:ncbi:9606">patients</span>
The authors are grateful to the families for their cooperation. Written consent for publication of the clinical pictures was obtained from the patients' parents.
###end p 130
###begin article-title 131
Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23
###end article-title 131
###begin article-title 132
Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease
###end article-title 132
###begin article-title 133
Loss-of-function mutations in SIP1 Smad interacting protein 1 results in a syndromic Hirschsprung disease
###end article-title 133
###begin article-title 134
Mowat-Wilson syndrome and mutation in the Zinc Finger Homeo Box 1B Gene: a new syndrome probably under-diagnosed
###end article-title 134
###begin article-title 135
"Mowat-Wilson" Syndrome with and without Hirschsprung Disease is a distinct, recognizable Multiple Congenital Anomalies-Mental Retardation Syndrome caused by Mutations in the Zinc finger homeobox 1 B gene (ZFHX1B)
###end article-title 135
###begin article-title 136
Hirschsprung disease, mental retardation, characteristic facial features and mutation in the gene ZFHX1B (SIP1): confirmation of the Mowat-Wilson syndrome
###end article-title 136
###begin article-title 137
Large scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with midline structure involvement
###end article-title 137
###begin article-title 138
Nonsense and frameshift mutations in ZFHX1B, encoding Smad interacting protein-1, cause a complex developmental disorder with a variety of clinical features
###end article-title 138
###begin article-title 139
Mowat-Wilson syndrome
###end article-title 139
###begin article-title 140
Further delineation of the phenotype associated with heterozygous mutation in ZFHX1B
###end article-title 140
###begin article-title 141
Characterisation of deletions of the ZFHX1B region and genotype-phenotype analysis in Mowat-Wilson syndrome
###end article-title 141
###begin article-title 142
Mowat-Wilson sindrome and mutation in the zinc finger homeo box 1B gene: a well defined clinical entity
###end article-title 142
###begin article-title 143
###xml 90 98 <span type="species:ncbi:9606">children</span>
Hirschsprung disease, mental retardation and dysmorphic facial features in five unrelated children
###end article-title 143
###begin article-title 144
Phenotypic variability of del(2)(q22-q23): report of a case and review of the literature
###end article-title 144
###begin article-title 145
Clinical features of a form of Hirschsprung's disease caused by a novel genetic abnormality
###end article-title 145
###begin article-title 146
Genitourinary anomalies are frequent in Mowat-Wilson sindrome with deletion/mutation in ZFHX1B (SIP1): report of 3 italian cases with hypospadias and review
###end article-title 146
###begin article-title 147
Recurrence of Mowat-Wilson syndrome in siblings with the same proven mutation
###end article-title 147
###begin article-title 148
Clinical and Mutational Spectrum of Mowat-Wilson Sindrome
###end article-title 148
###begin article-title 149
Clinical features and management issues in Mowat-Wilson syndrome
###end article-title 149
###begin article-title 150
A missense mutation in the ZFHX1B gene associated with an atypical Mowat-Wilson syndrome phenotype
###end article-title 150
###begin article-title 151
Atypical ZFHX1B mutation associated with a mild Mowat-Wilson syndrome phenotype
###end article-title 151
###begin article-title 152
###xml 20 28 <span type="species:ncbi:9606">patients</span>
ZFHX1B mutations in patients with Mowat-Wilson syndrome
###end article-title 152
###begin article-title 153
Frameshift mutation of the Zinc Finger Homeo Box 1 B gene in syndromic corpus callosum agenesis (Mowat-Wilson syndrome)
###end article-title 153
###begin article-title 154
Facial phenotype allows diagnosis of Mowat-Wilson syndrome in the absence of Hirschsprung disease
###end article-title 154
###begin article-title 155
Clinical and molecular analysis of Mowat-Wilson syndrome associated with ZFH1B mutations and deletions at 2q22-24.1
###end article-title 155
###begin article-title 156
First known microdeletion within the Wolf-Hirschhorn-syndrome critical region refines genotype-phenotype correlation
###end article-title 156
###begin article-title 157
Late infantile Hirschsprung disease-mental retardation syndrome with a 3-bp deletion in ZFHX1B
###end article-title 157
###begin article-title 158
Ocular coloboma and high myopia with Hirschsprung disease associated a novel ZFHX1B missense mutation and trisomy 21
###end article-title 158
###begin article-title 159
A 6 Mb deletion in band 2q22 due to a complex chromosome rearrangement associated with severe psychomotor retardation, microcephaly and distinctive dysmorphic facial features
###end article-title 159
###begin article-title 160
Pachygyria and cerebellar hypoplasia in Goldberg-Shprintzen syndrome
###end article-title 160
###begin article-title 161
###xml 42 49 <span type="species:ncbi:9606">patient</span>
Pachygyria and cerebellar hypoplasia in a patient with a 2q22-q23 deletion that includes the ZFHX1B gene
###end article-title 161
###begin article-title 162
Variation in aganglionic segment length of the enteric neural plexus in Mowat-Wilson sindrome
###end article-title 162
###begin article-title 163
Toward the effective surveillance of hypospadias
###end article-title 163
###begin article-title 164
Mowat-Wilson sindrome
###end article-title 164
###begin article-title 165
###xml 64 67 <span type="species:ncbi:9606">Man</span>
Electronic Database Information: Online MendelianInheritance in Man (OMIM)
###end article-title 165
###begin article-title 166
New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites
###end article-title 166
###begin article-title 167
SIP1, a novel zinc finger/homeodomain repressor, interacts with smad proteins and binds to 5'CACCT sequences in candidate target genes
###end article-title 167
###begin article-title 168
The role of transcription factors involved in TGFbeta superfamily signaling during development
###end article-title 168
###begin article-title 169
Structural insights on Smad function in TGFbeta signaling
###end article-title 169
###begin article-title 170
###xml 44 49 <span type="species:ncbi:9606">human</span>
Expression of the SMADIP1 gene during early human development
###end article-title 170
###begin article-title 171
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
###xml 79 84 <span type="species:ncbi:9606">human</span>
Pleiotropic and diverse expression of ZFHX1B gene transcripts during mouse and human development supports the various clinical manifestations of the "Mowat-Wilson" syndrome
###end article-title 171
###begin article-title 172
Large Scale Deletion versus truncating mutations at the ZFHX1B locus in Mowat-Wilson syndrome: genotype-phenotype correlations
###end article-title 172
###begin article-title 173
Hirschsprung disease, associated syndromes, and genetics: a review
###end article-title 173
###begin article-title 174
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ZFHX1B</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice Lacking ZFHX1B, the Gene That Codes for Smad-Interacting Protein-1, Reveal a Role for Multiple Neural Crest Cell Defects in the Etiology of Hirschsprung Disease-Mental Retardation Syndrome
###end article-title 174
###begin article-title 175
Hirschsprung megacolon and cleft palate in two sibs
###end article-title 175
###begin article-title 176
A consanguineous family with Hirschsprung disease, microcephaly and mental retardation (Goldberg-Shprintzen syndrome)
###end article-title 176
###begin article-title 177
Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems
###end article-title 177
###begin article-title 178
Genetics of Hirschsrung disease
###end article-title 178
###begin article-title 179
Whither polygenic inheritance: mapping Hirschsprung disease
###end article-title 179
###begin article-title 180
Molecular screening of the ZFHX1B gene in prenatally diagnosed isolated agenesis of the corpus callosum
###end article-title 180

